New cancer drug shows promise in early trial
NCT ID NCT05577182
First seen Nov 03, 2025 · Last updated May 25, 2026 · Updated 23 times
Summary
This early-phase study tested a new drug called INCA32459 in 46 people with advanced cancers that had spread or couldn't be removed. The main goal was to check the drug's safety and find the best dose. Researchers also looked for signs that the drug might shrink tumors. The study is now complete.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANCIES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centro Integral Oncologico Clara Campal
Madrid, 28050, Spain
-
Centro Ricerche Cliniche Di Verona (Crc)
Verona, 37134, Italy
-
Chu Ucl Namur University Hospital Mont-Godinne
Yvoir, 05530, Belgium
-
Cliniques Universitaires Ucl Saint-Luc
Brussels, 01200, Belgium
-
Hospital Quironsalud Barcelona
Barcelona, 08023, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario Quironsalud Madrid
Pozuelo de Alarcón, 28223, Spain
-
Ico Institut Catala D Oncologia
L'Hospitalet de Llobregat, 08906, Spain
-
The Angeles Clinic and Research Institute
Los Angeles, California, 90025, United States
-
Universitair Ziekenhuis Antwerpen (Uza)
Edegem, 02650, Belgium
-
Universitair Ziekenhuis Brussel
Jette, 01090, Belgium
-
Universitair Ziekenhuis Gent
Ghent, 09000, Belgium
-
University of Texas Md Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.